Cited by 39Alzheimer's disease research and treatmentsLysosomal Storage Disorders ResearchAmyotrophic Lateral Sclerosis Research

Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia

Open access
Geier, Ethan G., Bourdenx, Mathieu, Storm, Nadia J., Cochran, J. Nicholas, Sirkis, Daniel W., Hwang, Ji-Hye, Bonham, Luke W., Ramos, Eliana Marisa +17 more·2019·Acta Neuropathologica

Abstract

Pathogenic variation in MAPT, GRN, and C9ORF72 accounts for at most only half of frontotemporal lobar degeneration (FTLD) cases with a family history of neurological disease. This suggests additional variants and genes that remain to be identified as risk factors for FTLD. We conducted a case-control genetic association study comparing pathologically diagnosed FTLD patients (n = 94) to cognitively normal older adults (n = 3541), and found suggestive evidence that gene-wide aggregate rare variant burden in MFSD8 is associated with FTLD risk. Because homozygous mutations in MFSD8 cause neuronal ceroid lipofuscinosis (NCL), similar to homozygous mutations in GRN, we assessed rare variants in MFSD8 for relevance to FTLD through experimental follow-up studies. Using post-mortem tissue from middle frontal gyrus of patients with FTLD and controls, we identified increased MFSD8 protein levels in MFSD8 rare variant carriers relative to non-variant carrier patients with sporadic FTLD and healthy controls. We also observed an increase in lysosomal and autophagy-related proteins in MFSD8 rare variant carrier and sporadic FTLD patients relative to controls. Immunohistochemical analysis revealed that MFSD8 was expressed in neurons and astrocytes across subjects, without clear evidence of abnormal localization in patients. Finally, in vitro studies identified marked disruption of lysosomal function in cells from MFSD8 rare variant carriers, and identified one rare variant that significantly increased the cell surface levels of MFSD8. Considering the growing evidence for altered autophagy in the pathogenesis of neurodegenerative disorders, our findings support a role of NCL genes in FTLD risk and suggest that MFSD8-associated lysosomal dysfunction may contribute to FTLD pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-018-1925-9

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Certain disease-associated proteins have been shown to impair lysosomal acidification.

    “Moreover, certain disease-associated proteins have been shown to impair lysosomal acidification.”

    From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [60]

    The Results section (“Lysosomal malfunctioning in MFSD8 rare variant carriers”; page not available) reports reduced lysosomal protein degradation in cells carrying FTLD-associated MFSD8 variants. It does not report a measurement or finding that these variants impair lysosomal acidification; searches for acidification and lysosomal pH returned only degradation-related passages. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Amyloid beta accumulation in neurons in mouse models of AD results in faulty lysosomal acidification.

    “In particular, amyloid beta accumulation in neurons in mouse models of AD has been shown to result in faulty lysosomal acidification.60”

    From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [60]

    The Results section on lysosomal malfunctioning reports impaired lysosomal degradation in cells from people carrying MFSD8 variants, not faulty lysosomal acidification in neurons of Alzheimer’s mouse models. Searches for amyloid beta, Alzheimer’s mouse models, and lysosomal acidification found no passage in our copy addressing the claimed causal relationship; page numbers were not available. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 68

  1. [2]Aiello C, Terracciano A, Simonati A, Discepoli G, Cannelli N, Claps D, Crow YJ, Bianchi M, Kitzmuller C, Longo D, Tavoni A, Franzoni E, Tessa A, Veneselli E, Boldrini R, Filocamo M, Williams RE, Bertini ES, Biancheri R, Carrozzo R, Mole SE, Santorelli FM (2009) Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis. Hum Mutat 30: E530– E540. doi: 10.1002/humu.20975 19177532 · DOI
  2. [3]Almeida MR, Macário MC, Ramos L, Baldeiras I, Ribeiro MH, Santana I (2016) Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation. Neurobiol Aging 41: 200.e1-200.e5. doi: 10.1016/j.neurobiolaging.2016.02.019 27021778 · DOI · Paper page
  3. [5]Auteri JS, Okada A, Bochaki V, Fred Dice J (1983) Regulation of intracellular protein degradation in IMR-90 human diploid fibroblasts. J Cell Physiol 115: 167– 174. doi: 10.1002/jcp.1041150210 6341382 · DOI
  4. [7]Bird TD (2009) Progranulin plasma levels in the diagnosis of frontotemporal dementia. Brain 132: 568– 9. doi: 10.1093/brain/awp009 19224898 PMC4455660 · DOI
  5. [8]Bolte S, Cordelières FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213– 32. doi: 10.1111/j.1365-2818.2006.01706.x 17210054 · DOI
  6. [9]Brandenstein L, Schweizer M, Sedlacik J, Fiehler J, Storch S (2016) Lysosomal dysfunction and impaired autophagy in a novel mouse model deficient for the lysosomal membrane protein Cln7. Hum Mol Genet 25: 777– 91. doi: 10.1093/hmg/ddv615 26681805 · DOI
  7. [10]Carson AR, Smith EN, Matsui H, Brækkan SK, Jepsen K, Hansen J-B, Frazer KA (2014) Effective filtering strategies to improve data quality from population-based whole exome sequencing studies. BMC Bioinformatics 15: 125. doi: 10.1186/1471-2105-15-125 24884706 PMC4098776 · DOI
  8. [11]Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin J-J, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920– 4. doi: 10.1038/nature05017 16862115 · DOI · Paper page
  9. [12]Cuervo AM, Dice JF, Knecht E (1997) A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J Biol Chem 272: 5606– 15 9038169
  10. [13]Do R, Kathiresan S, Abecasis GR (2012) Exome sequencing and complex disease: practical aspects of rare variant association studies. Hum Mol Genet 21: R1– 9. doi: 10.1093/hmg/dds387 22983955 PMC3459641 · DOI
  11. [14]Dubois B, Feldman H, Jacova C (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13: 614– 29. doi: 10.1016/S1474-4422(14)70090-0 24849862 · DOI · Paper page
  12. [15]Fuentes Fajardo K V, Adams D, NISC Comparative Sequencing Program CE, Mason CE, Sincan M, Tifft C, Toro C, Boerkoel CF, Gahl W, Markello T (2012) Detecting false-positive signals in exome sequencing. Hum Mutat 33: 609– 13. doi: 10.1002/humu.22033 22294350 PMC3302978 · DOI
  13. [16]Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76: 1006– 1014 21325651 PMC3059138
  14. [17]Götzl JK, Lang CM, Haass C, Capell A (2016) Impaired protein degradation in FTLD and related disorders. Ageing Res Rev 32: 122– 139. doi: 10.1016/j.arr.2016.04.008 27166223 · DOI
  15. [18]Han L, Zhu Y, Liu M, Zhou Y, Lu G, Lan L, Wang X, Zhao Y, Zhang XC (2017) Molecular mechanism of substrate recognition and transport by the AtSWEET13 sugar transporter. Proc Natl Acad Sci U S A 114: 10089– 10094. doi: 10.1073/pnas.1709241114 28878024 PMC5617298 · DOI
  16. [19]Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885– 9. doi: 10.1038/nature04724 16625204 · DOI · Paper page
  17. [21]Johnson CW, Melia TJ, Yamamoto A (2012) Modulating macroautophagy: a neuronal perspective. Future Med Chem 4: 1715– 31. doi: 10.4155/fmc.12.112 22924509 PMC3566761 · DOI
  18. [22]Kaushik S, Cuervo AM (2009) Methods to monitor chaperone-mediated autophagy. Methods Enzymol 452: 297– 324. doi: 10.1016/S0076-6879(08)03619-7 19200890 PMC4300957 · DOI
  19. [23]Kaushik S, Cuervo AM (2015) Proteostasis and aging. Nat Med 21: 1406– 15. doi: 10.1038/nm.4001 26646497 · DOI · Paper page
  20. [24]Kaushik S, Cuervo AM (2018) The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol 19: 365– 381. doi: 10.1038/s41580-018-0001-6 29626215 PMC6399518 · DOI
  21. [25]Kim E-J, Sidhu M, Gaus SE, Huang EJ, Hof PR, Miller BL, DeArmond SJ, Seeley WW (2012) Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex 22: 251– 9. doi: 10.1093/cercor/bhr004 21653702 PMC3256403 · DOI · Paper page
  22. [26]Koga H, Kaushik S, Cuervo AM (2010) Inhibitory effect of intracellular lipid load on macroautophagy. Autophagy 6: 825– 7. doi: 10.1096/fj.09-144519 20647740 · DOI
  23. [27]Kohan R, Pesaola F, Guelbert N, Pons P, Oller-Ramirez AM, Rautenberg G, Becerra A, Sims K, Xin W, Cismondi IA, Noher de Halac I (2015) The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina. Biochim Biophys Acta 1852: 2301– 2311. doi: 10.1016/j.bbadis.2015.05.003 25976102 · DOI
  24. [28]Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880– 884. doi: 10.1038/nature04723 16625205 · DOI · Paper page
  25. [29]Kousi M, Lehesjoki A-E, Mole SE (2012) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 33: 42– 63. doi: 10.1002/humu.21624 21990111 · DOI
  26. [30]Kousi M, Siintola E, Dvorakova L, Vlaskova H, Turnbull J, Topcu M, Yuksel D, Gokben S, Minassian BA, Elleder M, Mole SE, Lehesjoki A-E (2009) Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis. Brain 132: 810– 819. doi: 10.1093/brain/awn366 19201763 · DOI
  27. [31]Lee J-A, Gao F-B (2008) Roles of ESCRT in autophagy-associated neurodegeneration. Autophagy 4: 230– 2 18094607
  28. [32]Lee J, Sands ZA, Biggin PC (2016) A Numbering System for MFS Transporter Proteins. Front Mol Biosci 3: 21. doi: 10.3389/fmolb.2016.00021 27314000 PMC4889909 · DOI
  29. [33]Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, Christiani DC, Wurfel MM, Lin X (2012) Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet 91: 224– 237. doi: 10.1016/j.ajhg.2012.06.007 22863193 PMC3415556 · DOI
  30. [35]Lek M, Karczewski KJ, Minikel E V, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won H-H, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, Consortium EA (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536: 285– 291 27535533 PMC5018207
  31. [36]Lelieveld SH, Spielmann M, Mundlos S, Veltman JA, Gilissen C (2015) Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions. Hum Mutat 36: 815– 22. doi: 10.1002/humu.22813 25973577 PMC4755152 · DOI
  32. [37]Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754– 1760. doi: 10.1093/bioinformatics/btp324 19451168 PMC2705234 · DOI · Paper page
  33. [38]Mackenzie IR, Neumann M, Baborie A, Sampathu D, Du Plessis D, Jaros E, Perry R, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122: 111– 113 21644037 PMC3285143
  34. [39]Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJM, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DMA (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119: 1– 4. doi: 10.1007/s00401-009-0612-2 19924424 PMC2799633 · DOI · Paper page
  35. [40]Mandel H, Cohen Katsanelson K, Khayat M, Chervinsky I, Vladovski E, Iancu TC, Indelman M, Horovitz Y, Sprecher E, Shalev SA, Spiegel R (2014) Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene. Eur J Med Genet 57: 607– 12. doi: 10.1016/j.ejmg.2014.09.004 25270050 · DOI
  36. [41]Masureel M, Martens C, Stein RA, Mishra S, Ruysschaert J-M, Mchaourab HS, Govaerts C (2014) Protonation drives the conformational switch in the multidrug transporter LmrP. Nat Chem Biol 10: 149– 55. doi: 10.1038/nchembio.1408 24316739 PMC4749020 · DOI
  37. [42]McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89: 88– 100. doi: 10.1212/WNL.0000000000004058 28592453 PMC5496518 · DOI · Paper page
  38. [43]McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297– 1303. doi: 10.1101/gr.107524.110 20644199 PMC2928508 · DOI · Paper page
  39. [45]Menzies FM, Fleming A, Rubinsztein DC (2015) Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 16: 345– 57. doi: 10.1038/nrn3961 25991442 · DOI · Paper page
  40. [46]Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C (2008) Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 71: 1496– 9. doi: 10.1212/01.wnl.0000334277.16896.fa 18981371 · DOI
  41. [47]Miller ZA, Mandelli ML, Rankin KP, Henry ML, Babiak MC, Frazier DT, Lobach I V., Bettcher BM, Wu TQ, Rabinovici GD, Graff-Radford NR, Miller BL, Gorno-Tempini ML (2013) Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 136: 3461– 3473. doi: 10.1093/brain/awt242 24056533 PMC3808687 · DOI
  42. [48]Mole SE, Cotman SL (2015) Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochim Biophys Acta 1852: 2237– 41. doi: 10.1016/j.bbadis.2015.05.011 26026925 PMC4567481 · DOI
  43. [49]Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19: 983– 97. doi: 10.1038/nm.3232 23921753 · DOI · Paper page
  44. [50]Olszewska DA, Lonergan R, Fallon EM, Lynch T (2016) Genetics of Frontotemporal Dementia. Curr Neurol Neurosci Rep 16: 107. doi: 10.1007/s11910-016-0707-9 27878525 · DOI
  45. [51]Olszewska DA, Lonergan R, Fallon EM, Lynch T (2016) Genetics of Frontotemporal Dementia. Curr Neurol Neurosci Rep 16: 107. doi: 10.1007/s11910-016-0707-9 27878525 · DOI
  46. [53]Orenstein SJ, Kuo S-H, Tasset I, Arias E, Koga H, Fernandez-Carasa I, Cortes E, Honig LS, Dauer W, Consiglio A, Raya A, Sulzer D, Cuervo AM (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16: 394– 406. doi: 10.1038/nn.3350 23455607 PMC3609872 · DOI · Paper page
  47. [54]Patel B, Cuervo AM (2015) Methods to study chaperone-mediated autophagy. Methods 75: 133– 140. doi: 10.1016/j.ymeth.2015.01.003 25595300 PMC4355229 · DOI
  48. [55]Pedersen BP, Kumar H, Waight AB, Risenmay AJ, Roe-Zurz Z, Chau BH, Schlessinger A, Bonomi M, Harries W, Sali A, Johri AK, Stroud RM (2013) Crystal structure of a eukaryotic phosphate transporter. Nature 496: 533– 6. doi: 10.1038/nature12042 23542591 PMC3678552 · DOI
  49. [57]Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559– 575 17701901 PMC1950838
  50. [59]Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, Knopman D, Kertesz A, Mesulam M, Salmon DP, Galasko D, Chow TW, Decarli C, Hillis A, Josephs K, Kramer JH, Weintraub S, Grossman M, Gorno-Tempini M-LL, Miller BM (2007) Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 21: S14– 8. doi: 10.1097/WAD.0b013e31815c3445 18090417 · DOI
  51. [60]Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, Isaacs AM, Authier A, Ferrari R, Fox NC, Mackenzie IR, Warren JD, de Silva R, Holton J, Revesz T, Hardy J, Mead S, Rossor MN (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73: 1451– 1456 19884572 PMC2779007
  52. [61]Roosing S, van den Born LI, Sangermano R, Banfi S, Koenekoop RK, Zonneveld-Vrieling MN, Klaver CCW, van Lith-Verhoeven JJC, Cremers FPM, den Hollander AI, Hoyng CB (2015) Mutations in MFSD8, Encoding a Lysosomal Membrane Protein, Are Associated with Nonsyndromic Autosomal Recessive Macular Dystrophy. Ophthalmology 122: 170– 179. doi: 10.1016/j.ophtha.2014.07.040 25227500 · DOI
  53. [62]Saftig P, Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10: 623– 35. doi: 10.1038/nrm2745 19672277 · DOI
  54. [63]See TM, LaMarre AK, Lee SE, Miller BL (2010) Genetic causes of frontotemporal degeneration. J Geriatr Psychiatry Neurol 23: 260– 268 20938042
  55. [64]Sharifi A, Kousi M, Sagné C, Bellenchi GC, Morel L, Darmon M, Hulková H, Ruivo R, Debacker C, El Mestikawy S, Elleder M, Lehesjoki A-E, Jalanko A, Gasnier B, Kyttälä A (2010) Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis. Hum Mol Genet 19: 4497– 514. doi: 10.1093/hmg/ddq381 20826447 PMC3298853 · DOI
  56. [65]Shyr C, Tarailo-Graovac M, Gottlieb M, Lee JJ, van Karnebeek C, Wasserman WW (2014) FLAGS, frequently mutated genes in public exomes. BMC Med Genomics 7: 64. doi: 10.1186/s12920-014-0064-y 25466818 PMC4267152 · DOI
  57. [67]Siintola E, Topcu M, Aula N, Lohi H, Minassian BA, Paterson AD, Liu X-Q, Wilson C, Lahtinen U, Anttonen A-K, Lehesjoki A-E (2007) The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter. Am J Hum Genet 81: 136– 146. doi: 10.1086/518902 17564970 PMC1950917 · DOI
  58. [69]Smith KR, Damiano J, Franceschetti S, Carpenter S, Canafoglia L, Morbin M, Rossi G, Pareyson D, Mole SE, Staropoli JF, Sims KB, Lewis J, Lin W-L, Dickson DW, Dahl H-H, Bahlo M, Berkovic SF (2012) Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 90: 1102– 7. doi: 10.1016/j.ajhg.2012.04.021 22608501 PMC3370276 · DOI · Paper page
  59. [70]Steenhuis P, Herder S, Gelis S, Braulke T, Storch S (2010) Lysosomal targeting of the CLN7 membrane glycoprotein and transport via the plasma membrane require a dileucine motif. Traffic 11: 987– 1000. doi: 10.1111/j.1600-0854.2010.01073.x 20406422 · DOI
  60. [71]Tartaglia MC, Sidhu M, Laluz V, Racine C, Rabinovici GD, Creighton K, Karydas A, Rademakers R, Huang EJ, Miller BL, DeArmond SJ, Seeley WW (2010) Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol 119: 365– 74. doi: 10.1007/s00401-009-0605-1 19876635 PMC2832091 · DOI
  61. [72]Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76: 4350– 4 388439 PMC411572
  62. [73]Wang K, Li M, Hakonarson H (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164. doi: 10.1093/nar/gkq603 20601685 PMC2938201 · DOI
  63. [75]Ward ME, Chen R, Huang H-Y, Ludwig C, Telpoukhovskaia M, Taubes A, Boudin H, Minami SS, Reichert M, Albrecht P, Gelfand JM, Cruz-Herranz A, Cordano C, Alavi MV., Leslie S, Seeley WW, Miller BL, Bigio E, Mesulam M-M, Bogyo MS, Mackenzie IR, Staropoli JF, Cotman SL, Huang EJ, Gan L, Green AJ (2017) Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med 9: eaah5642. doi: 10.1126/scitranslmed.aah5642 28404863 PMC5526610 · DOI · Paper page
  64. [76]Ward ME, Taubes A, Chen R, Miller BL, Sephton CF, Gelfand JM, Minami S, Boscardin J, Martens LH, Seeley WW, Yu G, Herz J, Filiano AJ, Arrant AE, Roberson ED, Kraft TW, Farese R V, Green A, Gan L (2014) Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med 211: 1937– 45. doi: 10.1084/jem.20140214 25155018 PMC4172214 · DOI
  65. [77]Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 805– 11. doi: 10.1038/nn.2575 20581817 PMC4038747 · DOI
  66. [78]Wu L, Yavas G, Hong H, Tong W, Xiao W (2017) Direct comparison of performance of single nucleotide variant calling in human genome with alignment-based and assembly-based approaches. Sci Rep 7: 10963. doi: 10.1038/s41598-017-10826-9 28887485 PMC5591230 · DOI
  67. [79]Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM (2010) The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67: 161– 170 20142524 PMC2901991
  68. [80]van der Zee J, Mariën P, Crols R, Van Mossevelde S, Dillen L, Perrone F, Engelborghs S, Verhoeven J, D’aes T, Ceuterick-De Groote C, Sieben A, Versijpt J, Cras P, Martin J-J, Van Broeckhoven C (2016) Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD. Neurol Genet 2: e102. doi: 10.1212/NXG.0000000000000102 27668283 PMC5027801 · DOI

Cited by

Sorted by citations

Authors
Geier, E. G., Bourdenx, M., Storm, N. J., Cochran, J. N., Sirkis, D. W., Hwang, J.-H., Bonham, L. W., Ramos, E. M., Diaz, A., Van Berlo, V., Dokuru, D., Nana, A. L., Karydas, A., Balestra, M. E., Huang, Y., Russo, S. P., Spina, S., Grinberg, L. T., Seeley, W. W., Myers, R. M., Miller, B. L., Coppola, G., Lee, S. E., Cuervo, A. M., & Yokoyama, J. S.
Affiliations
  • University of California, San Francisco (US)
  • Albert Einstein College of Medicine (US)
  • HudsonAlpha Institute for Biotechnology (US)
  • Howard Hughes Medical Institute (US)
  • University of California, Los Angeles (US)
  • Gladstone Institutes (US)
Corresponding author
Yokoyama, Jennifer S.
Venue
Acta Neuropathologica
Published
2018-10-31
Volume
137
Issue
1
Pages
71-88
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2898961633
Cited by
39
References
10
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 9 · 2021: 5 · 2020: 3 · 2019: 5
FWCI
2.23
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Bluefield Project to Cure FTD
  • Rainwater Charitable Foundation
  • Association for Frontotemporal Degeneration (Susan Marcus Memorial Fund Clinical Research Grant)
  • Larry L. Hillblom Foundation (2016-A-005-SUP)
  • National Institute on Aging (K01 AG049152, NIA P01 AG1972403, P50 AG023501, R01 AG023501, R01 AG048030, NS079725, AG054108)
  • National Institutes of Health (RC1 AG035610, R01 AG26938, AG050404)
  • Takeda Pharmaceutical Company Limited
  • National Institute of Neurological Disorders and Stroke (P30 NS062691)
  • John Douglas French Alzheimer’s Foundation
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal lobar degeneration, frontotemporal dementia, MFSD8, neuronal ceroid lipofuscinosis, rare variants, genetic risk factors, lysosomal dysfunction, autophagy, lysosomal storage disease
MeSH terms
Aged, Female, Humans, Lysosomes, Male, Middle Aged, Mutation, Neuronal Ceroid-Lipofuscinoses, Risk Factors, Pick Disease of the Brain, Membrane Transport Proteins, Intercellular Signaling Peptides and Proteins, Genetic Association Studies, Frontotemporal Lobar Degeneration, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review